Thrombomodulin as a marker of endothelium damage in some clinical conditions

European Journal of Internal Medicine

Volumn 11, Issue 2, 2000, Pages 79-84

  Remková, Anna ^a   Kováčová, Eva ^a   Príkazská, Marianna ^b   Kratochvíl'Ová, Helena ^a  

^a Physics and Informatics   (Slovakia)

^b Research Institute of Nutrition Slovakia   (Slovakia)

Author keywords

Crohn's disease; Essential hypertension; Gastric carcinoma

Indexed keywords

MARKER; THROMBOMODULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENDOTHELIUM INJURY; ENZYME IMMUNOASSAY; ESSENTIAL HYPERTENSION; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; STOMACH CARCINOMA; ULCERATIVE COLITIS; VASCULAR ENDOTHELIUM;

EID: 0343618584     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00066-2     Document Type: Article

References (24)

1. Takano S., Kimura S., Ohdama S., Aoki N. Plasma thrombomodulin in health and diseases. Blood. 76:1990;2024-2029.
2. Boffa M.C., Karmochkine M., Bérard M. Plasma thrombomodulin as a marker of endothelium damage. Nouv Rev Fr Hematol. 33:1991;529-530.
3. Iwashima Y., Sato T., Watanabe K., Ooshima E., Hiraishi S., Ishii H., Kazama M., Makino I. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes. 39:1990;983-988.
4. Karmochkine M., Boffa M.C., Piette J.C., Cacoub P., Wechsler B., Godeau P., Juhan I., Weiller P.J. Increase in plasma thrombomodulin in lupus erythematosus with antiphospholipid antibodies. Blood. 79:1992;837-838.
5. Pecháň J., Okrucká A. Diltiazem inhibits the spontaneous platelet aggregation in essential hypertension. Cardiology. 79:1991;116-119.
6. Okrucká A., Pecháň J., Kratochvíl'ová H. Effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril on endothelial and platelet functions in essential hypertension. Platelets. 9:1998;63-67.
7. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology. 70:1976;439-444.
8. Dacie J.V., Lewis S.M. Practical haematology. 1991;Churchill Livingstone, Edinburgh.
9. Funiak S., Kubisz P., Kvetenský J., Cronberg S. Von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens. 36:1995;483-485.
10. Trifiletti A., Barbera N., Pizzoleo M.A., Lasco A., Lucifora S., Leone G., Soraci S., Pedulla M., Frisina N. Haemostatic variables in arterial hypertension. Haemostasis. 25:1995;237-240.
11. Trifiletti A., Barbera N., Pizzoleo M.A., Leone G., Lucifora S., Soraci S., Scamardi R., Pedulla M., Frisina N. Hemostatic disorders associated with arterial hypertension and peripheral arterial disease. J Cardiovasc Surg. 36:1995;483-485.
12. Naruse M., Kawana M., Hifumi S., Naruse K., Yoshihara I., Oka T., Kato Y., Monzen C., Kurimoto F., Ohsumi K., Hosoda S., Demura H. Plasma immunoreactive endothelin, but not thrombomodulin, is increased in patients with essential hypertension and ischemic heart disease. J Cardiovasc Pharmacol. 17:(suppl 7):1991;S471-S474.
13. Nilsson T.K., Hellsten G., Amiral J. Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sample. Blood Coagul Fibrinolysis. 4:1993;455-458.
14. Seigneur M., Dufourcq P., Conri C., Constans J., Mercié P., Pruvost A., Amiral J., Midy D., Baste J.C., Boisseau M.R. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res. 71:1993;423-431.
15. Seki Y., Takahashi H., Shibata A., Aizawa Y. Plasma levels of thrombomodulin and lipoprotein (a) in patients with cerebral thrombosis. Blood Coagul Fibrinolysis. 8:1997;391-396.
16. Seigneur M., Dufourcq P., Conri C. Plasma thrombomodulin - new approach of endothelial damage. Int Angiol. 12:1993;85-93.
17. Conway E.M., Nowakowski B. Biologically active thrombomodulin is synthesized by adherent synovial fluid cells and is elevated in synovial fluid of patients with rheumatoid arthritis. Blood. 81:1993;726-733.
18. Himmereich G., Riewald M., Rosch R., Blumhard G., Neuhaus P., Roissant R., Riess H. Thrombomodulin: A marker for endothelial damage during orthotopic liver transplantation. Am J Hematol. 47:1994;1-5.
19. Esmon N.L. Thrombomodulin. Semin Thromb Hemost. 13:1987;454-463.
20. Lindahl A.K., Boffa M.C., Abilgaard U. Increased plasma thrombomodulin in cancer patients. Thromb Haemost. 69:1993;112-114.
21. Hamatake M., Ishida T., Mitsudomi T., Akazawa K., Sugimachi K. Prognostic value and clinicopathological correlation of thrombomodulin in squamous cell carcinoma of the human lung. Clin Cancer Res. 2:1996;763-766.
22. Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost. 65:1991;618-623.
23. Silverberg J.M., Gordon S., Zucker S. Identification of tissue factor in two pancreatic cancer cell lines. Cancer Res. 49:1989;5443-5447.
24. Bajaj M.S., Kuppuswamy M.N., Saito H., Spitzer S.G., Bajaj S.P. Cultured normal hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA. 87:1990;8869-8873.